Form 8-K - Current report:
SEC Accession No. 0001628280-22-017989
Filing Date
2022-06-24
Accepted
2022-06-24 17:22:19
Documents
12
Period of Report
2022-06-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20220622.htm   iXBRL 8-K 40337
  Complete submission text file 0001628280-22-017989.txt   179994

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20220622.xsd EX-101.SCH 1893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20220622_lab.xml EX-101.LAB 24831
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20220622_pre.xml EX-101.PRE 13037
6 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20220622_htm.xml XML 11254
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 221040963
SIC: 2834 Pharmaceutical Preparations